Adage Capital Partners
APEN

Adage Capital Partners’s Apollo Endosurgery, Inc. APEN Stock Holding History

Adage Capital Partners’s Portfolio APEN Stock Details APEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-416,000
Closed -$3.51M – 1161
2021
Q4 		$3.51M Buy
416,000
+260,032
+167% +$2.27M 0.01% 842
2021
Q3 		$1.41M Buy
+155,968
New +$1.34M ﹤0.01% 904

Other funds holding APEN

CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Adage Capital Partners's APEN Position: Q1 2022 in Review

Adage Capital Partners sold out of Apollo Endosurgery, Inc. (APEN) in Q1 2022, closing a stake of 416,000 shares — an estimated $3.51M sold.

Adage Capital Partners first reported a position in APEN in Q3 2021 and held it in 2 quarters. The position peaked at $3.51M in Q4 2021. 71 funds tracked by Wall St. Rank hold APEN as of Q1 2022.

  • Adage Capital Partners reported no remaining Apollo Endosurgery, Inc. position as of Q1 2022 after selling out during the quarter.
  • Adage Capital Partners sold 416,000 Apollo Endosurgery, Inc. shares in Q1 2022, an estimated $3.51M.
  • Adage Capital Partners first reported a position in Apollo Endosurgery, Inc. in Q3 2021 and held it in 2 quarters.
  • Adage Capital Partners's Apollo Endosurgery, Inc. position peaked at $3.51M in Q4 2021.
  • 71 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q1 2022.

Based on Adage Capital Partners's 13F filing for Q1 2022, filed 16 May 2022.